• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    • News
      All News Research Reports
    • Reports

    P
    Pharmaceuticals & Biotech.
    SECTOR | 07 Apr 2021

    Jan-Mar'21 Earnings Preview - Tepid growth on a low base

    buy
    Pharmaceuticals & Biotech.
    by Prabhudas Lilladhar
    Prabhudas Lilladhar
    Diagnostic companies would benefit from rising COVID cases throughout the country leading to higher RT-PCR testing in 4QFY21. Even with reduction in COVID testing prices for multiple times in last few months, it will likely...
    Copy Link Share on Share on Share on Share on
    Alert  
    More from Pharmaceuticals & Biotech.
    Recommended
    Five Interesting Stocks Today - September 12, 2025
    The Baseline | 12 Sep 2025, 04:39PM
    Market closes higher, Hindustan Copper announces a Rs 2,000 crore capex
    Trendlyne Marketwatch | 12 Sep 2025, 04:00PM
    Volume-led growth, price stabilization and new US launches boost Indian pharma
    | 25 Mar 2024
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd